Acquisition of Flame Biosciences - Sale of FL-101/FL (Details) - Flame - AlmataBio, Inc - Acquired In-process research and development (Sale Agreement) - USD ($) $ in Thousands		9 Months Ended	12 Months Ended
Dec. 06, 2023	Sep. 30, 2024	Dec. 31, 2023
Acquisition of Flame Biosciences
Consideration, non-refundable	$ 500	$ 500	$ 500
Acquired IPR&D	0		$ 0
Milestone payments to received		$ 0
Achievement of regulatory approval and commercial milestone
Acquisition of Flame Biosciences
Milestone payments entitled to receive	$ 70,000

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration